Endocannabinoids and Schizophrenia

por Desfossés, Joëlle, Stip, Emmanuel, Bentaleb, Lahcen Ait, Potvin, Stéphane
Publicado 2010

Relationships between Brain Structure and Metabolic Changes in Schizophrenia Patients Treated with Olanzapine: A Voxel-Based Morphometric Study

por Letourneau, Genevieve, Bentaleb, Lahcen Ait, Stip, Benjamin, Luck, David, Stip, Emmanuel
Publicado 2011

Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia

por Desfossés, Joëlle, Stip, Emmanuel, Bentaleb, Lahcen Ait, Lipp, Olivier, Chiasson, Jean-Pierre, Furtos, Alexandra, Venne, Karine, Kouassi, Edouard, Potvin, Stéphane
Publicado 2012

Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case–Control Trial with Quetiapine

por Zhornitsky, Simon, Stip, Emmanuel, Desfossés, Joelle, Pampoulova, Tania, Rizkallah, Élie, Rompré, Pierre-Paul, Bentaleb, Lahcen Aït, Lipp, Olivier, Chiasson, Jean-Pierre, Gendron, Alain, Potvin, Stéphane
Publicado 2011